The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer

por Jessica A. Moerland, Di Zhang, Lyndsey A. Reich, Sarah Carapellucci, Beth Lockwood, Ana S. Leal, Teresa Krieger-Burke, Bilal Aleiwi, Edmund Ellsworth, Karen T. Liby
Publicado 2020